Moshe Finel
- Molecular Biology top 2%
- Pharmacology top 0.05%
- Oncology top 2%
- Pediatrics, Perinatology and Child Health top 2%
- Pharmacology top 2%
- Co-authors
- Mårten WikströmAnne PuustinenMika KurkelaRisto KostiainenMichael H. CourtAnna MajanderTuomas HaltiaJari Yli‐Kauhaluoma
- Topics
- Pharmacogenetics and Drug Metabolism (84 papers)Drug Transport and Resistance Mechanisms (42 papers)Photosynthetic Processes and Mechanisms (26 papers)
- Partner nations
- FinlandUnited StatesChina
In The Last Decade
Moshe Finel
155 papers receiving 5.9k citations
Peers
Comparison fields: 5 of 131
- Molecular Biology 3.5k
- Pharmacology 1.9k
- Oncology 1.0k
- Pediatrics, Perinatology and Child Health 502
- Pharmacology 483
Countries citing papers authored by Moshe Finel
This map shows the geographic impact of Moshe Finel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe Finel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe Finel more than expected).
Fields of papers citing papers by Moshe Finel
This network shows the impact of papers produced by Moshe Finel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe Finel. The network helps show where Moshe Finel may publish in the future.
Co-authorship network of co-authors of Moshe Finel
This figure shows the co-authorship network connecting the top 25 collaborators of Moshe Finel. A scholar is included among the top collaborators of Moshe Finel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moshe Finel. Moshe Finel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 8 | |
| 4 | 17 | |
| 5 | 18 | |
| 6 | 8 | |
| 7 | 24 | |
| 8 | 11 | |
| 9 | 6 | |
| 10 | 29 | |
| 11 | 7 | |
| 12 | 18 | |
| 13 | 91 | |
| 14 | 17 | |
| 15 | 12 | |
| 16 | 33 | |
| 17 | 42 | |
| 18 | 193 | |
| 19 | 61 | |
| 20 | 11 |
About Moshe Finel
Moshe Finel is a scholar working on Pharmacology, Oncology and Clinical Biochemistry, having authored 156 papers that have together received 6.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (84 papers), Drug Transport and Resistance Mechanisms (42 papers) and Photosynthetic Processes and Mechanisms (26 papers). The work is most often cited by research in Pharmacology (1.9k citations), Clinical Biochemistry (371 citations) and Molecular Biology (3.5k citations). Moshe Finel has collaborated with scholars based in Finland, United States and China. Frequent co-authors include Mårten Wikström, Anne Puustinen, Mika Kurkela, Risto Kostiainen, Michael H. Court, Anna Majander, Tuomas Haltia, Jari Yli‐Kauhaluoma, Jouni Hirvonen and Anna Radomińska‐Pandya. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.